Generative AI for Healthcare: Xaira Therapeutics Launches with $1 Billion Funding ARCH Venture Partners and Foresite Labs have invested $1 billion in AI-driven drug discovery firm Xaira Therapeutics, aiming to revolutionize therapeutic product development by leveraging design expertise. by Quincy Jon